Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;31(3):182-195.
doi: 10.11005/jbm.2024.31.3.182. Epub 2024 Aug 31.

Body Composition, Sarcopenia, and Serum Myokines in Acromegaly: A Narrative Review

Affiliations

Body Composition, Sarcopenia, and Serum Myokines in Acromegaly: A Narrative Review

Arthur Costa Inojosa et al. J Bone Metab. 2024 Aug.

Abstract

Patients with active acromegaly have a higher percentage of lean body mass, a lower percentage of fat body mass, and an increase in their extracellular water compartment compared to healthy individuals. However, muscle function appears to be compromised in patients with acromegaly, with some experiencing worsened physical performance and sarcopenia. Myokine alterations, insulin resistance, dysregulation of protein metabolism, muscle oxidative stress, neuromuscular junction impairment, and increased ectopic intramuscular fat deposits may play roles in muscle dysfunction in patients with acromegaly.

Keywords: Acromegaly; Body composition; Myokines; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Flow chart of literature search. a)Ultrasonography, total body potassium, or total body water.
Fig. 2
Fig. 2
Body composition alterations and possible mechanisms for muscle impairment in patients with acromegaly. a)Measured through multifrequency bioelectrical impedance analysis, dual energy X-ray absorptiometry or magnetic resonance imaging. b)Trans-sphenoidal surgery or octreotide. GH, growth hormone; IGF-1, insulin-like growth factor 1.
None

Similar articles

Cited by

References

    1. Daly AF, Beckers A. The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am. 2020;49:347–55. doi: 10.1016/j.ecl.2020.04.002. - DOI - PubMed
    1. Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382:937–50. doi: 10.1056/NEJMra1810772. - DOI - PubMed
    1. Ritvonen E, Löyttyniemi E, Jaatinen P, et al. Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer. 2016;23:469–80. doi: 10.1530/erc-16-0106. - DOI - PubMed
    1. Dal J, Leisner MZ, Hermansen K, et al. Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. J Clin Endocrinol Metab. 2018;103:2182–8. doi: 10.1210/jc.2017-02457. - DOI - PubMed
    1. Melmed S. Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med. 2019;380:2551–62. doi: 10.1056/NEJMra1817346. - DOI - PubMed